Kolosis BIO
-
Biologics
Kolosis BIO and MTF Biologics Forge Strategic Partnership to Enter Surgical Incision Market
Salt Lake City, Utah, May 31, 2023/OrthoSpineNews/ – Kolosis BIO (Kolosis), a leading provider of biologics solutions, and MTF Biologics, a…
Read More » -
Biologics
Kolosis BIO and MTF Biologics Extend Exclusive Agreement
SALT LAKE CITY, Utah, February 14, 2023/OrthoSpineNews/ – Kolosis BIO (Kolosis), a leading provider of orthobiologics solutions, and MTF Biologics, a…
Read More » -
Biologics
Kolosis BIO Announces Strong 2022 Results
Kolosis bone grafts continue to gain widespread adoption, now available in over 370 hospitals and surgical facilities across 46 statesThe…
Read More » -
Biologics
Kolosis BIO Announces 2021 Results
• Kolosis bone grafts available in over 270 hospitals and surgical facilities in 46 states • Grafts utilized in approximately 6000…
Read More » -
Biologics
Kolosis BIO and MTF Biologics Announce Launch of Kore Fiber™
February 17, 2021 SALT LAKE CITY–(BUSINESS WIRE)–Kolosis BIO, LLC (Kolosis) announced today, in collaboration with MTF Biologics (MTF), the market…
Read More »